The carbohydrate-deficient glycoprotein (CDG) syndromes (CDGS) are a series of autosomal recessive enzyme deficiencies which result in incomplete glycosylation of plasma proteins. CDGS types Ia and Ib have been related to deficiencies of phosphomannomutase and phosphomannose isomerase, respectively, while CDGS type II results from a deficiency of N-acetylglucosaminyltransferase II. Secondary CDG syndromes are associated with galactosaemia and hereditary fructose intolerance. The diagnosis of CDGS is most easily made by studying the glycoforms of suitable marker proteins using either electrophoresis or isoelectric focusing. This paper reviews the structure of the glycan chains of proteins and structural alterations in CDGS. It also outlines analytical techniques which are useful in the laboratory study of protein glycoforms and the diagnosis of CDGS.
BrandliAW. Mammalian glycosylation mutants as tools for the analysis and reconstitution of protein transport. Biochem J1991; 276: 1–12.
12.
SchachterH.Coordination between enzyme specificity and intracellular compartmentation in the control of protein-bound oligosaccharide biosynthesis. Biol Cell1984; 51: 133–46.
13.
AbeijonCHirschbergCB. Topography of glycosylation reactions in the endoplasmic reticulum. Trends Biochem Sci1992; 17: 32–6.
14.
SilbersteinSGilmoreR.Biochemistry, molecular biology, and genetics of the oligosaccharyltransferase. FASEB J1996; 10: 849–58.
15.
MacGillivrayRTAMendezEShewaleJGSinhaSKLineback-ZinsJBrewK.The primary structure of transferrin. J Biol Chem1983; 258: 3543–53.
16.
FuDvan HalbeekH.N-glycosylation site mapping of human serotransferrin by serial lectin affinity chromatography, fast atom bombardment mass spectrometry, and 1H nuclear magnetic resonance spectroscopy. Anal Biochem1992; 206: 53–63.
17.
de JongGvan EijkHG. Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilised pH gradients. Electrophoresis1988; 9: 589–98.
18.
SpessM.The asialoglycoprotein receptor—a model for endocytotic transport receptors. Biochemistry1990; 29: 10008–19.
19.
IobstSTDrickamerK.Selective sugar binding to the carbohydrate recognition domains of the rat hepatic and macrophage asialoglycoprotein receptors. J Biol Chem1996; 271: 6686–93.
20.
JaekenJVandershureren-LodewyckxMCasaerP.Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased arylsulphatase A and increased CSF protein: A new syndrome?Pediatr Res1980; 14: 179.
JaekenJvan EijkHGvan der HeulCCorbeelLEeckelsREggermontE.Sialic acid deficient serum and cerebrospinal fluid transferrin in a newly recognised genetic syndrome. Clin Chim Acta1984; 144: 245–7.
23.
HarrisonHHMillerK.L.Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: Pathognomonic finding of two-dimensional electrophoresis. Clin Chem1992; 38: 1390–3.
24.
HuguesHTissotJ-DMesserliBMarkertMMuntaeASkladalDMicroheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: Apparent deficiencies in clusterin and serum amyloid P. J Lab Clin Med1997; 129: 412–21.
25.
HagbergBABlennowGFristianssonBStiblerH.Carbohydrate-deficient glycoprotein syndromes: Peculiar group of new disorders. Paed Neurol1993; 9: 255–62.
26.
JaekenJCarchonHStiblerH.The carbohydrate-deficient glycoprotein syndromes: Pre-Golgi and Golgi disorders?Glycobiology1993; 3: 423–8.
27.
WinchesterBClaytonPMianNdi-TomasoEDellAKeirG.The carbohydrate-deficient glycoprotein syndromes: An experiment of nature in glycosylation. Biochem Soc Trans1995; 23: 185–8.
HorslenSPClaytonPTHardingBNHallNAKeirGWinchesterBG. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch Dis Child1991; 66: 1027–32.
32.
ClaytonPTWinchesterBGKeirG.Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis1992; 15: 857–61.
33.
SilvaGarcia MTDe CastroJStiblerHSimonRYrigoyenChasco AMateosFPrenatal hypertrophic cardiomyopathy and pericardial effusion in carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis1996; 19: 257–9.
van der KnaapMSWeversRAMonnensLJakobsCJaekenJvan WukJAE. Congenital nephrotic syndrome: A novel phenotype of type 1 carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis1996; 19: 789–91.
36.
JensenPRHansenFJSkovbyF.Cerebellar hypoplasia in children with the carbohydrate-deficient glycoprotein syndrome. Neuroradiology1995; 37: 328–30.
37.
AkaboshiSOhnoKTakeshitaK.Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome. Neuroradiology1995; 37: 491–5.
38.
PavoneLFiumaraABaroneRRizzoRButtitaPDobynsWBOlivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome Type 1. J Neurol1996; 243: 700–5.
39.
HolzbachUHanefeldFHelmsGHanickeWFrahmJ.Localised proton magnetic resonance spectroscopy of cerebral abnormalities in children with carbohydrate-deficient glycoprotein syndrome. Acta Paediatr1995; 84: 781–6.
40.
FiumaraABaroneRButtitaPDi PietroMScuderiANigroFCarbohydrate deficient glycoprotein syndrome type I: Ophthalmic aspects in four Sicilian patients. Br J Opthalmol1994; 78: 845–6.
41.
CasteelsISpileersWLeysALagaeLJaekenJ.Evolution of ophthalmic and electrophysiological findings in identical twin sisters with the carbohydrate deficient glycoprotein syndrome type I over a period of 14 years. Br J Ophthalmol1996; 80: 900–2.
42.
SkladalDSperlWHenryHBachmannC.Congenital cataract and familial brachydactyly in carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis1996; 19: 251–2.
43.
StiblerHBlennowGKristianssonBLinderhammerHHagbergB.Carbohydrate-deficient glycoprotein syndrome: Clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatr1994; 57: 552–6.
44.
KristianssonBStiblerHWideL.Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Acta Paediatr1995; 84: 655–60.
45.
PinedaMPaviaCVilasecaMAFerrerITemudoTChabasANormal pubertal development in a female with carbohydrate deficient glycoprotein syndrome. Arch Dis Child1996; 74: 242–3.
46.
YamashitaKOkhuraTIdeoHOhnoKKanaiM.Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome. J Biochem1993; 114: 766–9.
47.
YamashitaKIdeoHOfkuraTFukushimaKYuasaIOhnoKSugar chains of serum transferrin from patients with carbohydrate-deficient glycoprotein syndrome: Evidence of asparigine-N-linked oligosaccharide transfer deficiency. J Biol Chem1993; 268: 5783–9.
48.
KrasnewichDMHoltGDBrantlyMSkovbyFRedwineJGahlWA. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology1995; 5: 503–10.
49.
PowellLDPanneerselvamKVijRDiazSManziABuistNCarbohydrate-deficient glycoprotein syndrome: Not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis?J Clin Invest1994; 94: 1901–9.
50.
KnauerRLehleLHanefeldFvon FiguraK. Normal N-oligosaccharyltransferase activity in fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis1994; 17: 541–4.
51.
Van SchaftingenEJaekenJ.Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome. FEBS Lett1995; 377; 318–20.
PanneerselvamKFreezeHH. Enzymes involved in the synthesis of mannose-6-phosphate from glucose are normal in carbohydrate-deficient glycoprotein syndrome fibroblasts. Biochem Biophys Res Commun1995; 208: 517–22.
54.
AltonGKjaergaardSEtchisonJRSkovbyFFreezeHH. Oral ingestion of mannose elevated blood mannose levels: A first step towards a potential therapy for carbohydrate-deficient glycoprotein syndrome type 1. Biochem Mol Med1997; 60: 127–33.
55.
OhkuraTFukushimaKKurisakaASagamiHOguraKOhnoKA partial deficiency of dehydrodolichol reduction is a cause of carbohydrate-deficient glycoprotein syndrome type 1. J Biol Chem1997; 272: 6868–75.
56.
YamashitaKOhnoK.Carbohydrate-deficient glycoprotein syndrome type 1. In: MontreuilJVliegenthartJFGSchachterH, eds. Glycoproteins and Disease. Amsterdam: Elsevier, 1996: 443–53.
57.
HillmenPBesslerMMasonPJWatkinsWMLuzzattoL.Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal haemoglobinuria. Proc Natl Acad Sci1993; 90: 5272–6.
58.
EdebolE-OWahlstromK.Genetic and epidemiological aspects of the carbohydrate-deficient glycoprotein syndrome. Acta Paed Scand1993; Suppl 375: 63–5.
59.
MatthijsGSchollenEPirardMBudarfMLSchaftingenEVCassimanJ-J.Phosphomannomutase (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localised on chromosome 22q13. Genomics1997; 40: 41–7.
60.
WadaYSakamotoM.Isolation of the human phosphomannomutase gene (PMM1) and assignment to chromosome 22q13. Genomics1997; 39: 416–7.
61.
MatthijsGSchollenEPardonEVeiga-Da-CunhaMJaekenJCassimanJ-JMutation in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein 1 syndrome (Jaeken syndrome). Nature Genet1997; 16: 88–92.
62.
MartinssonTBjursellCStiblerHKristianssonBSkovbyFJaekenJLinkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. Hum Mol Genet1994; 3: 2037–42.
63.
MatthijsGLegiusESchollenEVandenberkPJaekenJBaroneREvidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type 1 (CDG1). Genomics1996; 35: 597–9.
64.
BjursellCStiblerHWahlstromJKristianssonBSkovbyFStrommePFine mapping of the gene for carbohydrate-deficient glycoprotein syndrome type 1 (CDG1): Linkage disequilibrium and founder effect in Scandinavian families. Genomics1997; 39: 247–53.
65.
FiumaraABaroneRButtitaPMussoRPavoneLNigroFHaemostatic studies in carbohydrate-deficient glycoprotein syndrome type 1. Thromb Haemost1996; 76: 502–4.
66.
StiblerHHolzbachUTengbornLKristianssonB.Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type 1. Blood Coagul Fibrinolysis1996; 7: 502–4.
67.
MacchiaPEHarrisonHHScherbergNHSunthornthepvarakulTJaekenJRefetoffS.Thyroid function tests and characterisation of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type 1. J Clin Endocrinol Metab1995; 80: 3744–9.
68.
SubhedarNVIsherwoodDMDavidsonDC. Hyperglycinaemia in a child with carbohydrate-deficient glycoprotein syndrome type 1. J Inher Metab Dis1996; 19: 796–7.
69.
CharlwoodJClaytonPJohnsonAKeirGMianNWinchesterB.A case of the carbohydrate-deficient glycoprotein syndrome type 1 (CDGS Type 1) with normal phosphomannomutase activity. J Inher Metab Dis1997; 20: 817–27.
70.
NiehuesRHasilikMAltonGKörnerCSchiebe-SukumarMKochHGCarbohydrate-deficient glycoprotein syndrome type 1b: Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest1998; 101: 1414–20.
71.
de la FuenteMPenasPSolsA.Mechanism of mannose toxicity. Biochem Biophys Res Commun1986; 140: 51–5.
72.
RamaekersVTStiblerHKintJJaekenJ.A new variant of the carbohydrate deficient glycoproteins syndrome. J Inher Metab Dis1991; 23: 385–8.
73.
JaekenJDecockPStiblerHVangeetCKintJRamaekersVCarbohydrate-deficient glycoprotein syndrome type II. J Inher Metab Dis1993; 16: 1041.
74.
JaekenJSchachterHCarchonHDecockPCoddevilleBSpikG.Carbohydrate-deficient glycoprotein syndrome type II: A deficiency in Golgi-localised N-acetylglucosaminyltransferase II. Arch Dis Child1994; 71: 123–7.
75.
CharukJHMTanJBernardiniMHaddadSReithmeierRAFJaekenJCarbohydrate-deficient glycoprotein syndrome II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidifiedserum lysis test (HEMPAS). Eur J Biochem1995; 230: 797–805.
76.
StiblerHWesterbergBHanefeldFHagbergB.Carbohydrate-deficient glycoprotein (CDG) syndrome—a new variant, Type III. Neuropediatrics1993; 24: 51–2.
LöfKKoivulaTSeppäKFukunagaTSiilanaukeeP.Semi-automatic method for the determination of different isoforms of carbohydrate-deficient transferrin. Clin Chim Acta1993; 217: 175–86.
79.
YuasaIOhnoKHashimotoKIijimiaKYamashitaKTakeshitaK.Carbohydrate-deficient glycoprotein syndrome: Electrophoretic study of multiple serum glycoproteins. Brain Dev1995; 17: 13–9.
80.
GravelPWalzerCAubryCBalantLPYersinBHochstrasserDFNew alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun1996; 220: 79–85.
81.
RohrerJSAvdalovicN.Separation of human transferrin isoforms by high performance pellicular anion-exchange chromatography. Protein Expr Purif1996; 7: 39–44.
82.
IourinOMattuTSMianNKeirGWinchesterBDwekRAThe identification of abnormal glycoforms of serum transferrin in carbohydrate-deficient glycoprotein syndrome type 1 by capillary zone electrophoresis. Glycoconj J1996; 13: 1031–42.
83.
SetaNBarnierAHochedezFBesnardM-ADurandG.Diagnostic value of western blotting in carbohydrate-deficient glycoprotein syndrome. Clin Chim Acta1996; 254: 131–40.
84.
ClaytonPWinchesterBDi TomasoEYoungEKeirGRodeckC.Carbohydrate-deficient glycoprotein syndrome: Normal glycosylation in the fetus. Lancet1993; 341: 956.
van PeltJBakkerJAVelmansMHSpaapenLJM. Carbohydrate-deficient transferrin values in neonatal and umbilical cord serum. J Inher Metab Dis1996; 19: 253–6.
87.
StiblerHCederbergB.Diagnosis of the carbohydrate-deficient glycoprotein syndrome by analysis of transferrin in filter paper blood spots. Acta Paediatr1993; 82: 55–9.
88.
StiblerHKristianssonB.Analysis of transferrin and α1-fetoprotein in amniotic fluid and neonatal serum: A possible means of indirect prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paed Scand1991; Suppl 375: 32–8.
89.
CharlwoodJClaytonPKeirGMianNYoungEWinchesterB.Prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling. Prenat Diagn1998; 18: 693–9.
90.
HoltonJBLeonardJV. Editorial: Clouds still gathering over galactosaemia. Lancet1994; 344: 1242–3.
91.
SchweitzerSShinYJakobsCBrodehlJ.Long term outcome in 134 patients with galactosaemia. Eur J Paed1993; 152: 36–43.
92.
BerryGTNissimILinZMazurATGibsonJBSegalS.Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet1995; 346: 1073–4.
93.
PetryKGreinixHTNudelmanEEisenHHakamoriS-ILevyHLCharacterisation of a novel biochemical abnormality in galactosaemia: Deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem Med Metab Biol1991; 46: 93–104.
94.
CharlwoodJClaytonPKeirGMianNWinchesterB.Defective galactosylation of serum transferrin in galactosaemia. Glycobiology1998; 8: 351–7.
JaekenJPirardMAdamowiczMPronickaEvan SchaftingenE.Inhibition of phosphomannose isomerase by fructose 1-phosphate: An explanation for defective N-glycosylation in hereditary fructose intolerance. Paed Res1996; 40: 764–6.
